New Animal Drugs for Use in Animal Feeds; Monensin and Tylosin

Resumo

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly and Co. The supplemental NADA provides for use of monensin and tylosin Type A medicated articles for making Type B and C cattle feeds, the Type C cattle feed to be fed at a range of 60 to 90 milligrams of tylosin per head per day (mg/hd/day) rather than the currently approved 90 mg/hd/day.